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Introduction
Motor neuron disease (MND) is a neurodegenerative 
disease with typical onset between the 6th and 7th decade, 
determining progressive and relentless motor deterioration 
involving both upper and lower motor neurons (UMN 
and LMN). Several variants at onset are recognized, 
aside from the “classic” or “spinal” variant, that may 
display, especially at the very beginning, clinical features 
indicative of exclusive UMN or LMN involvement—such 
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as “monomelic” or “flail arm” presentations, known to be 
associated with a relatively longer disease duration (1). At 
the opposite end of the amyotrophic lateral sclerosis (ALS) 
clinical spectrum there are primary lateral sclerosis (PLS) 
and progressive muscular atrophy (PMA), characterized by 
an earlier age of onset, a significantly longer average survival, 
and by degeneration of only UMNs or LMNs, respectively, 
during the entire disease course (2,3). PLS usually begins 
as a spastic paraparesis displaying an ascending symmetrical 
pattern of progression, although asymmetrical, multifocal or 
pseudobulbar presentations have been reported. The absence 
of development of LMN signs after 4 years of onset allows to 
classify the disease as PLS rather than classical ALS (4).
An isolated pyramidal syndrome, with complete absence 
of LMN signs, is a rare phenotype in the context of MND 
(less than 4% of total cases), especially if restricted to only 
one limb (5). It may raise the suspect of a MND at the 
very beginning, especially if presenting in an insidious way, 
but it is essential to exclude other more likely diagnostic 
possibilities (i.e., lesional causes) and to consider the 
progression of the syndrome over time. The role of MR 
in confirming an extensive UMN involvement of possible 
degenerative etiology has been highlighted by previous 
works (6-8). Moreover, the evaluation of white matter 
abnormalities by diffusion tensor imaging (DTI) proved 
useful for distinguishing between ALS and PLS (9,10). 
Here we describe a case of MND presenting as pure spastic 
monoparesis in which advanced MR techniques gave a 
substantial contribution in confirming the diagnosis and 
assessing the severity of UMN involvement. 
Case presentation
An 81-year-old woman presented a left upper limb weakness 
with subacute (18 months) onset, which spread from the 
hand to the whole arm. She also experienced progressive 
stiffness and clumsiness in fine movements, eventually 
leading to severe functional impairment. Neurological 
examination showed moderate-severe spastic monoparesis 
of the left upper limb with pathological hyperreflexia and 
Hoffmann, Troëmner and Bechterew signs. She presented 
an almost complete paralysis of all left hand movements. 
There was only mild distal muscular atrophy, while 
fasciculations were absent. The contralateral upper limb 
and the lower limbs displayed normal strength, tone and 
reflexes. No pyramidal signs in the other districts, nor 
bulbar or respiratory involvement were present. There 
were no superficial or deep sensory disturbances in the 
whole body. Neuropsychological assessment showed normal 
cognitive functions. She denied familiarity for neurological 
disorders and her past medical history included achalasia, 
erythema nodosum and cervical spondyloarthrosis. 
Extensive laboratory analyses, including endocrine and 
autoimmune evaluations, screening for neoplastic markers, 
anti-ganglioside and anti-neuronal antibodies were not 
contributive. The only significant alterations were the 
following: ESR (first hour) 80 mm, CRP 1.08 mg/dL, 
fibrinogen 683 mg/dL, ferritin 739 ng/mL. Serum CK was 
equal to 31 U/L. Anti-nuclear antibodies were present at 
high titer (1:640) with homogeneous pattern. No anti-ENA 
was detected.
Motor and sensory nerve conduction study was normal. 
No denervation was found in the examined muscles 
(deltoid, first dorsal interosseous and biceps) in the left 
upper arm. Motor unit potential showed normal amplitude 
and duration with diffuse reduction of recruitment. A 
Magstim 200 stimulator was used to deliver transcranial and 
paravertebral stimuli through a circular coil. Motor evoked 
potentials were recorded bilaterally from biceps brachii 
and abductor digiti minimi. Central motor conduction 
time (CMCT) was calculated by subtracting the peripheral 
conduction time from spinal cord to muscles (peripheral 
motor latency, PML) from the latency of responses evoked 
by cortical stimulation (central motor latency, CML). We 
found no cortical response recording from left abductor 
digiti minimi and a pathological lengthening of CMCT 
recording from left biceps brachii, measuring 23.75 msec 
(with normal PML, 5 msec, and markedly prolonged CML, 
28.75 ms).
The patient underwent brain and spine MR assessment 
on a 3 Tesla scanner (Trio, Siemens Medical Systems, 
Erlangen, Germany). The acquisition protocol included, 
beside conventional sequences such as T2w or FLAIR, a 
structural T1w volumetric sequence used for co-registration 
with DTI for the evaluation of the corticospinal tract 
(CST) integrity, by means of tractography analysis, and 
magnetic resonance spectroscopy (MRS) at the level of 
the motor cortex (MC). Structural T1w volumes were 
acquired by three-dimensional Magnetization-Prepared 
RApid Gradient-Echo sequence (MPRAGE; TE =3.4 ms; 
TR =1900 ms; TI =900 ms; Flip Angle =9°, FOV =250; slice 
plane = axial; slice thickness =1 mm; voxel size =1×1×1 mm3; 
number of slices =160).
A 2D Multi-voxel MRS Spin Echo (point-resolved 
spectroscopy) sequence was acquired,  with water 
suppression by means of selective excitation (TE: 270 ms, 
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FOV 160×160 mm2, acquisition matrix 16×16, slice 
thickness: 15 mm, zero-filled to a voxel size of 5×5×15 mm3) 
as a single axial slice centered at the level of the “hand 
knobs” of the MC. Diffusion weighted images (DWI) 
were acquired with diffusion gradients oriented along 64 
non-collinear directions (TR =5,200 ms, TE =82 ms, flip 
angle =90°, matrix 128×128, 3 mm thick axial slices, 8 B0 
values with a diffusion weighting b =1,000 s/mm2). DTI 
data were preliminarily corrected for head movements and 
eddy currents distortions using Medical Image Processing, 
Analysis and Visualization software (MIPAV, http://
mipav.cit.nih.gov/). Each diffusion-weighted volume was 
deformed to match the corresponding B0 volume using 
a cubic Lagrangian interpolation. Diffusion sensitizing 
gradient directions were corrected according to the 
corresponding deformation vectors and a diffusion-tensor 
model was fitted at each voxel using Diffusion Toolkit 
(http://trackvis.org/dtk), generating fractional anisotropy 
(FA), and mean diffusivity (MD) maps. Spectroscopy 
data were analyzed using the software available on the 
scanner (Syngo MR B17). Processing included Fourier 
transformation, Gaussian filtering in the time domain, and 
phase and baseline correction, followed by identification 
of the choline (Cho, centered at 3.22 ppm), creatine and 
phosphocreatine (Cr, 3.02 ppm), and N-Acetyl-Aspartate 
(NAA, 2.02 ppm) peaks, and fitting of the corresponding 
integrals under the curve. The ratio of NAA to Crea + 
Cho was used as marker of UMN loss/dysfunction. Both 
DTI and MRS results were compared to data obtained 
with the same analysis on a group of five age-matched 
healthy controls (HC).
Brain magnetic resonance imaging (MRI) showed 
prominent atrophy and T2-hypointensity of the right 
MC and milder atrophy of the post-central gyrus and of 
the entire parietal lobe, with no evidence of remarkable 
cerebrovascular disease along the pyramidal system, thus 
ruling out an ischemic etiology (Figure 1A,B). No signal 
abnormalities were present on the conventional sequences 
along the CST. 
Compared to HC, DTI and MRS analysis showed 
impairment of both CST diffusion and MC metabolite 
concentration, respectively (Figure 1C-E), with a greater 
involvement of the right side. Namely, the DTI analysis, using 
ROIs placed in the subcortical white matter of the precentral 
gyrus, showed reduced FA and increased MD (0.51±0.12 
and 858±111 mm2/s ×10−6, respectively) in the patient’s right 
CST compared to the left (0.55±0.13, and 806±108 mm2/s 
×10−6, respectively), with marked asymmetry in terms of 
relative track counts (right = 33; left =74).
The corresponding DTI metrics in the HC group 
(Figure 1F) were: FA right: 0.54±0.14, left: 0.54±0.15; MD 
right: 748±102, left: 756±105 mm2/s ×10−6; track counts 
right: 165, left: 165. 
At MRS, a diffuse reduction of the NAA/Cho + Cr 
ratio was present in both MC areas, more prominent on 
the right (0.97) compared to the contralateral side (1.03) 
(Figure 1D,E), the ratio being clearly lower than the 
corresponding values in the HC group (right =1.32±0.12; 
left =1.29±0.11).
Spine MRI disclosed non-significant spondyloarthrosis, 
without alterations in spinal cord morphology or signal. 
Therefore, DTI at this level was not performed.
Discussion
ALS or MND is the most frequent neurodegenerative disease 
involving both UMNs and LMNs. Its main clinical variant 
(spinal variant) is typically asymmetric and distal at the onset. 
Several elements make our case an unusual presentation 
of MND: first, the late age of onset (8th decade), whereas 
sporadic MND classically begins between the 6th and the 7th 
decade of life and PLS even earlier (11). Another atypical 
aspect for MND is the subacute evolution of symptoms, 
which raised the suspicion of an ischemic or inflammatory, 
rather than degenerative, etiology. Also, the patient’s 
past medical history (achalasia, erythema nodosum), the 
increase of inflammatory indices (such as ESR, CRP, ferritin 
and fibrinogen) and the presence of ANA (antinuclear 
antibodies) at high titer, indicated the need of ruling out 
ischemic lesions of possible autoimmune origin. The third 
important point is the clinical phenotype displayed by our 
case, i.e., a spastic upper limb monoparesis. Among MND 
variants determining predominant upper limb impairment, 
monomelic and flail arm presentations mainly involve 
LMNs, with UMN signs possibly appearing during the 
disease course (12). Here, the clinical syndrome consisted 
of pure UMN features, and no LMN signs were present. 
Moreover, the electrophysiological examination completely 
excluded LMN involvement, and motor evoked potentials 
confirmed and underlined the damage along CST directed 
to the upper left limb, without appreciable alterations of 
central motor conduction to the other limbs. This “focal” 
impairment was again in favor of a lesional hypothesis (i.e., 
vascular or neoplastic), making MRI even more necessary. 
All similar cases reported in the literature were related to an 
ischemic etiology with acute onset. The only exception was 
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a case of anti-phospholipid antibody syndrome presenting 
with a progressive monoparesis due to an ischemic lesion 
at the level of the precentral cortex (13). In our case, 
“conventional” MRI showed no vascular lesions that could 
explain the clinical features allowing us to exclude an 
ischemic etiology (14). 
Therefore, we used advanced MR sequences in order 
to evaluate the whole CST, looking for focal or diffuse 
pathology along it. The DTI evaluation surprisingly 
evidenced bilateral  impairment of CST diffusion 
metrics, with clear right-left asymmetry, pointing to 
a neurodegenerative etiology (15), which clinically 
appeared less likely at that time. Then, the marked 
reduction of NAA/Cho + Cr ratio in the MC shown 
by MRS further supported the hypothesis of UMN 
degeneration (6-8).
However, the diagnostic conclusions in our case are 
hampered by the atypical age and modality of onset, 
which still hinder a precise diagnostic definition either by 
considering it as an early phase of classical ALS or as a PLS. 
In fact, since the disease started no more than 18 months 
before our clinical evaluation, a clinically pure diagnosis of 
PLS is not possible yet (4). In conclusion, in this particular 
case of MND, whose nosographic framing has not been 
fully defined, advanced MRI techniques with DTI and MRS 
proved to be of great usefulness in confirming a diffuse 
UMN involvement, possibly at a more advanced stage than 
its clinical expression (16).
A B C
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Figure 1 Diffuse involvement of the right CST and MC: MRI findings. Axial T2-weighted at the level of the “hand knob” of the MC (A); 
coronal FLAIR (B); DTI of the right (green) and left (red) CST superimposed on the coronal MPRAGE (C); and MRS of the right (D) and 
left (E) MC of the patient; DTI of the right (green) and left (red) CST superimposed on the coronal MPRAGE of an age-matched HC (F). 
Marked atrophy and hypointensity of both motor cortices, more prominent on the right side, are observed on T2-w images (A), with only 
scattered gliotic WM foci evident on FLAIR images (B). The right CST shows reduced DTI metrics, with a clear right-left asymmetry in 
terms of relative track counts (right =33; left =74) (C). At MRS, a reduction of the NAA/Cho + Cr ratio is present in both MC areas, more 
prominent on the right side (D,E). For comparison, the DTI of a 77-year-old female HC is also displayed (F). CST, corticospinal tract; MC, 
motor cortex; MRI, magnetic resonance imaging; DTI, diffusion tensor imaging; MPRAGE, Magnetization-Prepared RApid Gradient-Echo 
sequence; MRS, magnetic resonance spectroscopy; HC, healthy control; FLAIR, fluid attenuated inversion recovery; WM, white matter.
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